Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognition
Published version of a preprint
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
The CRL4 CRBN E3 ubiquitin ligase is the target of molecular glue degrader compounds that reprogram ligase specificity to induce the degradation of clinically relevant neosubstrate proteins. Known cereblon (CRBN) neosubstrates share a generalizable β-hairpin G-loop recognition motif that allows for the systematic exploration of the CRBN target space. Computational mining approaches using structure- and surface-based matchmaking algorithms predict more than 1600 CRBN-compatible G-loop proteins across the human proteome, including the newly discovered helical G-loop motif, and identify the noncanonical neosubstrate binding mode of VAV1 that engages CRBN through a molecular surface mimicry mechanism. This work broadens the CRBN target space, redefines rules for neosubstrate recognition, and establishes a platform for the elimination of challenging drug targets by repurposing CRL4 CRBN through next-generation molecular glue degraders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The compound-mediated interface between CRBN and KAT2ANTD not only lacks a G-loop structural motif but also does not contain a structural mimic of the canonical motif as seen in VAV1 (11).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [11]
In the citing paper
“We found that KAT2ANTD buries a substantial portion of both the CRBNNTD and CRBNCTD, forming a broad PPI that is distinct from the more hotspot-driven interfaces created by the G-loop neo-substrates (e.g., IKZF1(45), GSPT1(40)), the G-loop mimetic (VAV1(11)), and the non-G-loop (G3BP2(14)) (Fig 3F).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [11]
In the citing paper
“together these results show that the targetable universe of proteins degradable by CRBN-recruiting MGs is not limited to POIs that contain the G-loop degron motif (4), or its structural mimic (11).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [11]
In the citing paper
“While targets with G-loop-like motifs have only sampled a fraction of this PPI hotspot on the CRBN CULT domain25 (Fig. 5), the G3BP2 binding mode demonstrates how engagement of a separate region of the hotspot bypasses previous requirements for target engagement.”
From Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry (2026) · cites this paper as [25]
In the citing paper
“Strikingly, G3BP2 lacks key contacts with the CRBN CULT domain commonly involved in neosubstrate recruitment25–28, which distinguishes the binding mode of G3BP2 from other structurally characterized CRBN targets (Fig. 5a–d and Extended Data Fig. 10).”
From Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry (2026) · cites this paper as [25]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
ColabFold - Making protein folding accessible to all
Mirdita, M., Schütze, K., Moriwaki, Y., Heo, L., Ovchinnikov, S., & Steinegger, M. (2021) · doi:10.1101/2021.08.15.456425 · Cited by 9,391
Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., et al. (2019) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798319011471 · Cited by 7,953
Pfam: The protein families database in 2021
Mistry, J., Chuguransky, S., Williams, L., Qureshi, M., Salazar, G. A., Sonnhammer, E. L. L., Tosatto, S. C. E., Paladin, L., Raj, S., Richardson, L. J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa913 · Cited by 7,452
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,697
Improvements to the APBS biomolecular solvation software suite
Jurrus, E., Engel, D., Star, K., Monson, K., Brandi, J., Felberg, L. E., Brookes, D. H., Wilson, L., Chen, J., Liles, K., et al. (2018) · Protein Science · doi:10.1002/pro.3280 · Cited by 2,405
Paysan-Lafosse, T., Blum, M., Chuguransky, S., Grego, T., Pinto, B. L., Salazar, G. A., Bileschi, M. L., Bork, P., Bridge, A., Colwell, L., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac993 · Cited by 2,399
Efficient proximity labeling in living cells and organisms with TurboID
Branon, T. C., Bosch, J. A., Sanchez, A. D., Udeshi, N. D., Svinkina, T., Carr, S. A., Feldman, J. L., Perrimon, N., & Ting, A. Y. (2018) · Nature Biotechnology · doi:10.1038/nbt.4201 · Cited by 2,174
SMART: recent updates, new developments and status in 2020
Letunic, I., Khedkar, S., & Bork, P. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa937 · Cited by 2,151
Identification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136
Varadi, M., Bertoni, D., Magana, P., Paramval, U., Pidruchna, I., Radhakrishnan, M., Tsenkov, M., Nair, S., Mirdita, M., Yeo, J., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad1011 · Cited by 2,052
PANTHER : Making genome‐scale phylogenetics accessible to all
Thomas, P. D., Ebert, D., Muruganujan, A., Mushayahama, T., Albou, L., & Mi, H. (2022) · Protein Science · doi:10.1002/pro.4218 · Cited by 2,010
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Krönke, J., Udeshi, N. D., Narla, A., Grauman, P., Hurst, S. N., McConkey, M., Svinkina, T., Heckl, D., Comer, E., Li, X., et al. (2014) · Science · doi:10.1126/science.1244851 · Cited by 1,879
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Lu, G., Middleton, R. E., Sun, H., Naniong, M., Ott, C. J., Mitsiades, C. S., Wong, K.-K., Bradner, J. E., & Kaelin, W. G. (2014) · Science · doi:10.1126/science.1244917 · Cited by 1,583
New and continuing developments at PROSITE
Sigrist, C. J. A., de Castro, E., Cerutti, L., Cuche, B. A., Hulo, N., Bridge, A., Bougueleret, L., & Xenarios, I. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1067 · Cited by 1,562
NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
He, Y., Zeng, M. Y., Yang, D., Motro, B., & Núñez, G. (2016) · Nature · doi:10.1038/nature16959 · Cited by 1,295
Shape Complementarity at Protein/Protein Interfaces
Lawrence, M. C., & Colman, P. M. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1648 · Cited by 1,215
Nolen, B., Taylor, S., & Ghosh, G. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.024 · Cited by 1,167
DIALS: implementation and evaluation of a new integration package
Winter, G., Waterman, D. G., Parkhurst, J. M., Brewster, A. S., Gildea, R. J., Gerstel, M., Fuentes-Montero, L., Vollmar, M., Michels-Clark, T., Young, I. D., et al. (2018) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798317017235 · Cited by 1,115
A series of PDB-related databanks for everyday needs
Touw, W. G., Baakman, C., Black, J., te Beek, T. A. H., Krieger, E., Joosten, R. P., & Vriend, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1028 · Cited by 935
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 929
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
Krönke, J., Fink, E. C., Hollenbach, P. W., MacBeth, K. J., Hurst, S. N., Udeshi, N. D., Chamberlain, P. P., Mani, D. R., Man, H. W., Gandhi, A. K., et al. (2015) · Nature · doi:10.1038/nature14610 · Cited by 863
Deciphering interaction fingerprints from protein molecular surfaces using geometric deep learning
Gainza, P., Sverrisson, F., Monti, F., Rodolà, E., Boscaini, D., Bronstein, M. M., & Correia, B. E. (2020) · Nature Methods · doi:10.1038/s41592-019-0666-6 · Cited by 834
Self-citationA novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Matyskiela, M. E., Lu, G., Ito, T., Pagarigan, B., Lu, C.-C., Miller, K., Fang, W., Wang, N.-Y., Nguyen, D., Houston, J., et al. (2016) · Nature · doi:10.1038/nature18611 · Cited by 701
Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
Petzold, G., Fischer, E. S., & Thomä, N. H. (2016) · Nature · doi:10.1038/nature16979 · Cited by 620
Self-citationGandhi, A. K., Kang, J., Havens, C. G., Conklin, T., Ning, Y., Wu, L., Ito, T., Ando, H., Waldman, M. F., Thakurta, A., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12708 · Cited by 619
Plasticity in binding confers selectivity in ligand-induced protein degradation
Nowak, R. P., DeAngelo, S. L., Buckley, D., He, Z., Donovan, K. A., An, J., Safaee, N., Jedrychowski, M. P., Ponthier, C. M., Ishoey, M., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0055-y · Cited by 615
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
Sievers, Q. L., Petzold, G., Bunker, R. D., Renneville, A., Słabicki, M., Liddicoat, B. J., Abdulrahman, W., Mikkelsen, T., Ebert, B. L., & Thomä, N. H. (2018) · Science · doi:10.1126/science.aat0572 · Cited by 537
Self-citationDonovan, K. A., An, J., Nowak, R. P., Yuan, J. C., Fink, E. C., Berry, B. C., Ebert, B. L., & Fischer, E. S. (2018) · eLife · doi:10.7554/elife.38430 · Cited by 509
Anchorage of Microtubule Minus Ends to Adherens Junctions Regulates Epithelial Cell-Cell Contacts
Meng, W., Mushika, Y., Ichii, T., & Takeichi, M. (2008) · Cell · doi:10.1016/j.cell.2008.09.040 · Cited by 428
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396
Role of GTP Hydrolysis in Fission of Caveolae Directly from Plasma Membranes
Schnitzer, J. E., Oh, P., & McIntosh, D. P. (1996) · Science · doi:10.1126/science.274.5285.239 · Cited by 371
CRISPR activation and interference screens decode stimulation responses in primary human T cells
Schmidt, R., Steinhart, Z., Layeghi, M., Freimer, J. W., Bueno, R., Nguyen, V. Q., Blaeschke, F., Ye, C. J., & Marson, A. (2022) · Science · doi:10.1126/science.abj4008 · Cited by 315
PDB file parser and structure class implemented in Python
Hamelryck, T., & Manderick, B. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg299 · Cited by 266
Hansen, J. D., Correa, M., Nagy, M. A., Alexander, M., Plantevin, V., Grant, V., Whitefield, B., Huang, D., Kercher, T., Harris, R., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01928 · Cited by 240
De novo design of protein interactions with learned surface fingerprints
Gainza, P., Wehrle, S., Van Hall-Beauvais, A., Marchand, A., Scheck, A., Harteveld, Z., Buckley, S., Ni, D., Tan, S., Sverrisson, F., et al. (2023) · Nature · doi:10.1038/s41586-023-05993-x · Cited by 236
Self-citationSurka, C., Jin, L., Mbong, N., Lu, C.-C., Jang, I. S., Rychak, E., Mendy, D., Clayton, T., Tindall, E., Hsu, C., et al. (2021) · Blood · doi:10.1182/blood.2020008676 · Cited by 229
Molecular glue CELMoD compounds are regulators of cereblon conformation
Watson, E. R., Novick, S., Matyskiela, M. E., Chamberlain, P. P., H. de la Peña, A., Zhu, J., Tran, E., Griffin, P. R., Wertz, I. E., & Lander, G. C. (2022) · Science · doi:10.1126/science.add7574 · Cited by 208
Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH
Rossignol, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1628 · Cited by 198
The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron
Ichikawa, S., Flaxman, H. A., Xu, W., Vallavoju, N., Lloyd, H. C., Wang, B., Shen, D., Pratt, M. R., & Woo, C. M. (2022) · Nature · doi:10.1038/s41586-022-05333-5 · Cited by 195
From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation
Oleinikovas, V., Gainza, P., Ryckmans, T., Fasching, B., & Thomä, N. H. (2024) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-022123-104147 · Cited by 178
Self-citationDiscovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy
Bonazzi, S., d’Hennezel, E., Beckwith, R. E. J., Xu, L., Fazal, A., Magracheva, A., Ramesh, R., Cernijenko, A., Antonakos, B., Bhang, H.-E. C., et al. (2023) · Cell Chemical Biology · doi:10.1016/j.chembiol.2023.02.005 · Cited by 167
The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms
Fulcher, L. J., Bozatzi, P., Tachie-Menson, T., Wu, K. Z. L., Cummins, T. D., Bufton, J. C., Pinkas, D. M., Dunbar, K. J., Shrestha, S., Wood, N. T., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aao2341 · Cited by 135
Acute pharmacological degradation of Helios destabilizes regulatory T cells
Wang, E. S., Verano, A. L., Nowak, R. P., Yuan, J. C., Donovan, K. A., Eleuteri, N. A., Yue, H., Ngo, K. H., Lizotte, P. H., Gokhale, P. C., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00802-w · Cited by 124
Vav1: a key signal transducer downstream of the TCR
Tybulewicz, V. L. J., Ardouin, L., Prisco, A., et al. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00032.x · Cited by 121
Molecular glues and bifunctional compounds: Therapeutic modalities based on induced proximity
Schreiber, S. L. (2024) · Cell Chemical Biology · doi:10.1016/j.chembiol.2024.05.004 · Cited by 112
Sharp, T. V., Muñoz, F., Bourboulia, D., Presneau, N., Darai‐Ramqvist, E., Wang, H., Cannon, M., Butcher, D. N., Nicholson, A. G., Klein, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407123101 · Cited by 100
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction
Ting, P. Y., Borikar, S., Kerrigan, J. R., Thomsen, N. M., Aghania, E., Hinman, A. E., Reyes, A., Pizzato, N., Fodor, B. D., Wu, F., et al. (2024) · Science · doi:10.1126/science.adk6129 · Cited by 97
Latorre, E., Torregrossa, R., Wood, M. E., Whiteman, M., & Harries, L. W. (2018) · Aging · doi:10.18632/aging.101500 · Cited by 94
Continuous evolution of compact protein degradation tags regulated by selective molecular glues
Mercer, J. A. M., DeCarlo, S. J., Roy Burman, S. S., Sreekanth, V., Nelson, A. T., Hunkeler, M., Chen, P. J., Donovan, K. A., Kokkonda, P., Tiwari, P. K., et al. (2024) · Science · doi:10.1126/science.adk4422 · Cited by 82
Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs
Gemechu, Y., Millrine, D., Hashimoto, S., Prakash, J., Sanchenkova, K., Metwally, H., Gyanu, P., Kang, S., & Kishimoto, T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814446115 · Cited by 78
Structural basis of catalytic activation in human splicing
Schmitzová, J., Cretu, C., Dienemann, C., Urlaub, H., & Peña, V. (2023) · Nature · doi:10.1038/s41586-023-06049-w · Cited by 73
Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216
Teng, M., Lu, W., Donovan, K. A., Sun, J., Krupnick, N. M., Nowak, R. P., Li, Y.-D., Sperling, A. S., Zhang, T., Ebert, B. L., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01832 · Cited by 63
Lupas, A. N., Zhu, H., & Koryciński, M. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004023 · Cited by 53
Razumkov, H., Jiang, Z., Baek, K., You, I., Geng, Q., Donovan, K. A., Tang, M. T., Metivier, R. J., Mageed, N., Seo, P., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c06127 · Cited by 53
Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies
Renneville, A., Gasser, J. A., Grinshpun, D. E., Beltran, P. M. J., Udeshi, N. D., Matyskiela, M. E., Clayton, T., McConkey, M. E., Viswanathan, K., Tepper, A., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0105 · Cited by 51
Identification and structural basis of C-terminal cyclic imides as natural degrons for cereblon
Heim, C., Spring, A.-K., Kirchgäßner, S., Schwarzer, D., & Hartmann, M. D. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.11.001 · Cited by 51
The cyclimids: Degron-inspired cereblon binders for targeted protein degradation
Ichikawa, S., Payne, N. C., Xu, W., Chang, C., Vallavoju, N., Frome, S., Flaxman, H. A., Mazitschek, R., & Woo, C. M. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.01.003 · Cited by 50
A systematic analysis of the beta hairpin motif in the Protein Data Bank
DuPai, C. D., Davies, B. W., & Wilke, C. O. (2021) · Protein Science · doi:10.1002/pro.4020 · Cited by 40
Payne, S., Burney, M. J., McCue, K., Popal, N., Davidson, S. M., Anderson, R. H., & Scambler, P. J. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.06.017 · Cited by 37
A unifying Bayesian framework for merging X-ray diffraction data
Dalton, K. M., Greisman, J. B., & Hekstra, D. R. (2022) · Nature Communications · doi:10.1038/s41467-022-35280-8 · Cited by 37
Structure-based view of the druggable genome
Wang, J., Yazdani, S., Han, A., & Schapira, M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.02.006 · Cited by 36
Miñarro-Lleonar, M., Bertran‐Mostazo, A., Duro, J., Barril, X., & Juárez‐Jiménez, J. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01692 · Cited by 34
VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases
Neurath, M. F., & Berg, L. J. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.06.004 · Cited by 34
Cereblon neo-substrate binding mimics the recognition of the cyclic imide degron
Heim, C., Spring, A.-K., Kirchgäßner, S., Schwarzer, D., & Hartmann, M. D. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.051 · Cited by 33
Engal, E., Oja, K. T., Maroofian, R., Geminder, O., Le, T.-L., Marzin, P., Guimier, A., Mor, E., Zvi, N., Elefant, N., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.10.013 · Cited by 25
Genesis and regulation of C-terminal cyclic imides from protein damage
Xu, W., Zhao, Z., Su, M., Jain, A. D., Lloyd, H. C., Feng, E. Y., Cox, N., & Woo, C. M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2415976121 · Cited by 21
Zeng, L., Zhou, Z. G., Xu, J., Zhao, W., Wang, W., Huang, Y., Cheng, C., Xu, M., Xie, Y., & Mao, Y. (2001) · Cytogenetic and Genome Research · doi:10.1159/000057015 · Cited by 18
Shaheen, N., Kobayashi, K., Hiroki, T., Fukushige, T., Horiuchi, M., & Saheki, T. (1994) · Enzyme and Protein · doi:10.1159/000474998 · Cited by 13
Targeting guanine nucleotide exchange factors for novel cancer drug discovery
Bannoura, S. F., Khan, H. Y., Uddin, M. H., Mohammad, R. M., Pasche, B., & Azmi, A. S. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2368242 · Cited by 11
Engal, E., Oja, K. T., Maroofian, R., Geminder, O., Le, T.-L., Mor, E., Tzvi, N., Elefant, N., Zaki, M. S., Gleeson, J. G., et al. (2023) · medRxiv · doi:10.1101/2023.06.19.23291425 · Cited by 2
Research works printed but not linked: 1
- O. S. Smart, G. Bricogne, Multifaceted Roles of Crystallography in Modern Drug Discovery, NATO Science for Peace and Security Series (Springer, 2015), pp. 165–181.
Cited by
Unveiling the hidden interactome of CRBN molecular glues
Baek, K., Metivier, R. J., Burman, S. S. R., Bushman, J. W., Yoon, H., Lumpkin, R. J., Ryan, J. K., Abeja, D. M., Lakshminarayan, M., Yue, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62099-w · Cited by 89
Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics
Steger, M., Nishiguchi, G., Wu, Q., Schwalb, B., Shashikadze, B., McGowan, K., Actis, M., Aggarwal, A., Shi, Z., Price, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62829-0 · Cited by 32
High-throughput ligand diversification to discover chemical inducers of proximity
Shaum, J. B., Ordoño, M. M. I., Steen, E. A., Wenge, D. V., Cheong, H., Janowski, J., Hunkeler, M., Bilotta, E. M., Rutter, Z. J., Barta, P. A., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02137-2 · Cited by 45
“…indicate that CRBN makes concerted movements to accommodate the induced ENL interaction with a high degree of shape complementarity, which is congruent with emerging studies demonstrating that the CRBN surface is highly plastic and capable of accommodating diverse structural degrons 42,104–106 .”
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
Sylvain, A., Stoehr, N., Ma, F., Cernijenko, A., Schröder, M., Khoshouei, M., Vogelsanger, M., Schoenboerner, M., Burke, A., Rao, P., et al. (2025) · Cell Chemical Biology · doi:10.1016/j.chembiol.2025.06.005 · Cited by 23
Machine learning to predict de novo protein–protein interactions
Gaínza, P., Bunker, R. D., Townson, S. A., & Castle, J. C. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.04.013 · Cited by 27
Self-citation
Metadata
- Authors
- Petzold, G., Gainza, P., Annunziato, S., Lamberto, I., Trenh, P., McAllister, L. A., DeMarco, B., Schwander, L., Bunker, R. D., Zlotosch, M., SriRamaratnam, R., Gilberto, S., Langousis, G., Donckele, E. J., Quan, C., Strande, V., De Donatis, G. M., Alabi, S. B., Alers, J., Matysik, M., Staehly, C., Dubois, A., Osmont, A., Garskovas, M., Lyon, D., Wiedmer, L., Oleinikovas, V., Lieberherr, R., Rubin, N. T., Lam, D. T., Lucas, X., Liardo, E., Widlund, N. I., Ritzén, A., Caceres, R. M., Vigil, D., Tsai, J., Wallace, O., Peluso, M., Sadok, A., Tiedt, R., Paterson, A. M., Zarayskiy, V., Fasching, B., Bonenfant, D., Warmuth, M., Castle, J. C., & Townson, S. A.
- Affiliations
- Boston Foundation (US)
- Monte Rosa Therapeutics Inc, Boston, MA, USA.
- Corresponding author
- Petzold, Georg
- Castle, John C.
- Townson, Sharon A.
- ORCID
- Petzold, Georg
- Gainza, Pablo
- Annunziato, Stefano
- Trenh, Peter
- McAllister, Laura A.
- Bunker, Richard D.
- SriRamaratnam, Rohitha
- Gilberto, Samuel
- Langousis, Gerasimos
- Donckele, Etienne J.
- Quan, Chao
- Alabi, Shanique B.
- Matysik, Michelle
- Lyon, David
- Oleinikovas, Vladimiras
- Lieberherr, Raphael
- Lucas, Xavier
- Ritzén, Andreas
- Caceres, Ramon Miguel
- Tsai, Jennifer
- Wallace, Owen
- Peluso, Marisa
- Sadok, Amine
- Tiedt, Ralph
- Fasching, Bernhard
- Bonenfant, Debora
- Castle, John C.
- Townson, Sharon A.
- Venue
- Science
- Published
- 2025-07-03
- Volume
- 389
- Issue
- 6755
- Pages
- eadt6736-eadt6736
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4411983851
- Semantic Scholar
- 4bb4e874249f92d431945f892817b0fe43714a19
- Cited by
- 117
- References
- 73
- Citations by year
- 2026: 73 · 2025: 43
- FWCI
- 34.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- molecular glues, Vav1, protein degradation
- MeSH terms
- Humans, Protein Binding, Substrate Specificity, Molecular Mimicry, Amino Acid Motifs, Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing, Data Mining, Drug Repositioning, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.